113 related articles for article (PubMed ID: 19879234)
41. Antimicrobial response of a T cell-deficient host to cytokine therapy: effect of interferon-gamma in experimental visceral leishmaniasis in nude mice.
Murray HW; Hariprashad J; Aguero B; Arakawa T; Yeganegi H
J Infect Dis; 1995 May; 171(5):1309-16. PubMed ID: 7751708
[TBL] [Abstract][Full Text] [Related]
42. Multiple host defense defects in failure of C57BL/6 ep/ep (pale ear) mice to resolve visceral Leishmania donovani infection.
Murray HW; Hariprashad J; McDermott DF; Stoeckle MY
Infect Immun; 1996 Jan; 64(1):161-6. PubMed ID: 8557335
[TBL] [Abstract][Full Text] [Related]
43. Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response.
Das L; Datta N; Bandyopadhyay S; Das PK
J Immunol; 2001 Mar; 166(6):4020-8. PubMed ID: 11238649
[TBL] [Abstract][Full Text] [Related]
44. Mechanisms of depression of splenic natural killer cell function in C57BL/6 mice infected with Leishmania donovani.
Kirkpatrick CE; Farrell JP
Cell Immunol; 1984 Sep; 87(2):601-12. PubMed ID: 6205773
[TBL] [Abstract][Full Text] [Related]
45. Visceral Leishmania donovani infection in interleukin-13-/- mice.
Murray HW; Tsai CW; Liu J; Ma X
Infect Immun; 2006 Apr; 74(4):2487-90. PubMed ID: 16552085
[TBL] [Abstract][Full Text] [Related]
46. Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis.
Singh N; Sundar S
PLoS One; 2018; 13(6):e0199817. PubMed ID: 29953494
[TBL] [Abstract][Full Text] [Related]
47. Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro.
Kaye PM; Bancroft GJ
Infect Immun; 1992 Oct; 60(10):4335-42. PubMed ID: 1398944
[TBL] [Abstract][Full Text] [Related]
48. Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development.
Volpedo G; Pacheco-Fernandez T; Bhattacharya P; Oljuskin T; Dey R; Gannavaram S; Satoskar AR; Nakhasi HL
Front Immunol; 2021; 12():748325. PubMed ID: 34712235
[TBL] [Abstract][Full Text] [Related]
49. Early activated Th-1 type and dominantly diverse natural killer T (CD3⁺CD161⁺Vα24⁻) cells in bone marrow among visceral leishmaniasis patients.
Rai AK; Thakur CP; Seth T; Mitra DK
Int J Parasitol; 2011 Aug; 41(10):1069-77. PubMed ID: 21787777
[TBL] [Abstract][Full Text] [Related]
50. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection.
Gorak PM; Engwerda CR; Kaye PM
Eur J Immunol; 1998 Feb; 28(2):687-95. PubMed ID: 9521079
[TBL] [Abstract][Full Text] [Related]
51. Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity.
Prajeeth CK; Haeberlein S; Sebald H; Schleicher U; Bogdan C
Infect Immun; 2011 Jul; 79(7):2699-708. PubMed ID: 21518784
[TBL] [Abstract][Full Text] [Related]
52. Antigen recognition by effector T cells in antileishmanial defense.
Sypek JP; Panosian CB; Wyler DJ
J Infect Dis; 1985 Nov; 152(5):1057-63. PubMed ID: 2413143
[TBL] [Abstract][Full Text] [Related]
53. Splenic natural killer-cell activity in mice infected with Leishmania donovani.
Kirkpatrick CE; Farrell JP
Cell Immunol; 1984 Apr; 85(1):201-14. PubMed ID: 6201286
[TBL] [Abstract][Full Text] [Related]
54. Tumor necrosis factor alpha neutralization has no direct effect on parasite burden, but causes impaired IFN-γ production by spleen cells from human visceral leishmaniasis patients.
Singh N; Kumar R; Engwerda C; Sacks D; Nylen S; Sundar S
Cytokine; 2016 Sep; 85():184-90. PubMed ID: 27372917
[TBL] [Abstract][Full Text] [Related]
55. The innate immune response against Leishmania parasites.
Liese J; Schleicher U; Bogdan C
Immunobiology; 2008; 213(3-4):377-87. PubMed ID: 18406382
[TBL] [Abstract][Full Text] [Related]
56. Effect of continuous administration of interferon-gamma in experimental visceral leishmaniasis.
Murray HW
J Infect Dis; 1990 May; 161(5):992-4. PubMed ID: 2157773
[TBL] [Abstract][Full Text] [Related]
57. Nerve growth factor promotes killing of Leishmania donovani by macrophages through the induction of hydrogen peroxide.
Chiba R; Amagai Y; Tanaka A; Katakura K; Matsuda H
Microbes Infect; 2014 Aug; 16(8):702-6. PubMed ID: 24937592
[TBL] [Abstract][Full Text] [Related]
58. Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis.
Mukhopadhyay S; Bhattacharyya S; Majhi R; De T; Naskar K; Majumdar S; Roy S
Clin Diagn Lab Immunol; 2000 Mar; 7(2):233-40. PubMed ID: 10702498
[TBL] [Abstract][Full Text] [Related]
59. Macrophage subsets harbouring Leishmania donovani in spleens of infected BALB/c mice: localization and characterization.
Lang T; Avé P; Huerre M; Milon G; Antoine JC
Cell Microbiol; 2000 Oct; 2(5):415-30. PubMed ID: 11207597
[TBL] [Abstract][Full Text] [Related]
60. Immunotherapy with IL-2-stimulated splenocytes reduces in vitro the level of Leishmania donovani infection in peritoneal macrophages.
Eslami Z; Olivier M; Tanner CE
Int J Parasitol; 1995 Aug; 25(8):975-81. PubMed ID: 8550297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
